Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | AKT1 | P31749 | 2/20 | 0.36 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL8168614 | 0.98 | HSP90AA1 (0.45) | HSP90AA1TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL22513813 | 0.83 | HSP90AA1 (0.41) | HSP90AA1TSHRALDH1A1MEN1GAA | |
| SCHEMBL19687813 | 0.81 | HSP90AA1 (0.32) | HSP90AA1AKT1 | |
| SCHEMBL12305754 | 0.79 | HSP90AA1 (0.50) | HSP90AA1TSHRALDH1A1TDP1AKT1 | |
| SCHEMBL12305771 | 0.79 | HSP90AA1 (0.50) | HSP90AA1TSHRALDH1A1TDP1AKT1 | |
| SCHEMBL9094 | 0.79 | HSP90AA1 (0.50) | HSP90AA1TSHRALDH1A1TDP1AKT1 | |
| SCHEMBL13908046 | 0.76 | HSP90AA1 (0.47) | HSP90AA1TSHRALDH1A1HSD17B10TDP1 | |
| SCHEMBL5077963 | 0.76 | HSP90AA1 (0.55) | HSP90AA1ALDH1A1HSD17B10TDP1MEN1 | |
| SCHEMBL4606197 | 0.76 | HSP90AA1 (0.50) | HSP90AA1TSHRALDH1A1MEN1GAA | |
| SCHEMBL2392066 | 0.75 | HSP90AA1 (0.46) | HSP90AA1TSHRALDH1A1TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 818 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110721731-B | Supported catalyst and preparation method and application thereof | 万华化学集团股份有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-106810488-B | One class is used as GPR17 and CysLT1Compound of dual antagonist, preparation method and application thereof | 中国科学院上海药物研究所 | 2021-02-19 | — | — | CN | claimed |
| CN-110721731-A | Supported catalyst and preparation method and application thereof | 万华化学集团股份有限公司 | 2020-01-24 | — | — | CN | claimed |
| CN-106810488-A | One class is used as GPR17 and CysLT1The compound of dual antagonist, Preparation Method And The Use | 中国科学院上海药物研究所 | 2017-06-09 | — | — | CN | claimed |
| EP-2074210-A2 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | Biomatrica, INC. (US) | 2009-07-01 | — | — | EP | claimed |
| WO-2009038853-A2 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | BIOMATRICA, INC. (US) | 2009-03-26 | — | — | WO | claimed |
| US-20080176209-A1 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | BIOMATRICA, INC. (US) | 2008-07-24 | — | — | US | claimed |
| US-12637440-B2 | Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof | LG CHEM, LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| US-20260138987-A1 | MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS | CONTINEUM THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12630503-B2 | Method for producing benzopyranone compound and novel intermediate used therein | ILAB (KR) | 2026-05-19 | — | — | US | disclosed |
| EP-4731623-A1 | CARBOLINE COMPOUNDS AND USE THEREOF | PTC Therapeutics, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12565501-B2 | Muscarinic acetylcholine M1 receptor antagonists | CONTINEUM THERAPEUTICS, INC. (US) | 2026-03-03 | — | — | US | disclosed |
| US-12552783-B2 | Modulators of proteolysis and associated methods of use | ARVINAS OPERATIONS, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| EP-0174858-A1 | Isoindolinone derivatives, production and use thereof | Takeda Chemical Industries, Ltd. (JP) | 1986-03-19 | — | — | EP | disclosed |
| US-4528282-A | Amide derivatives | IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) | 1985-07-09 | — | — | US | disclosed |
| US-4489093-A | Insecticidal esters | ROUSSEL UCLAF (FR) | 1984-12-18 | — | — | US | disclosed |
| EP-0111105-A2 | Unsaturated aromatic amides as pesticides | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-06-20 | — | — | EP | disclosed |
| EP-0084941-A1 | Amide derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-08-03 | — | — | EP | disclosed |
| EP-0070204-A2 | Carboxylic beta-lactam compounds and the preparation thereof | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1983-01-19 | — | — | EP | disclosed |
| US-4065620-A | ANTIBIOTICS | ELI LILLY AND COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630503-B2 | Method for producing benzopyranone compound and novel intermediate used therein | TNF, NFKBIA, TNFRSF1A | HSP90AA1 932/4885TSHR 1818/4885ALDH1A1 524/4885 |
| US-12565501-B2 | Muscarinic acetylcholine M1 receptor antagonists | CHRM1, CHRM2, CHRM3 | HSP90AA1 3500/4885TSHR 52/4885ALDH1A1 1427/4885 |
| US-20260138987-A1 | MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS | CHRM1, CHRM5, CHRM3 | HSP90AA1 3805/4885TSHR 71/4885ALDH1A1 1512/4885 |
| US-20080176209-A1 | INTEGRATION OF SAMPLE STORAGE AND SAMPLE MANAGEMENT FOR LIFE SCIENCE | NEFM, DNASE1, DCTD | HSP90AA1 856/4885TSHR 3097/4885ALDH1A1 2900/4885 |
| US-12552783-B2 | Modulators of proteolysis and associated methods of use | CRBN, ADRM1, MDM2 | HSP90AA1 1854/4885TSHR 2253/4885ALDH1A1 3965/4885 |
| US-12637440-B2 | Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof | DGAT2, DGAT1, DLAT | HSP90AA1 1698/4885TSHR 2348/4885ALDH1A1 885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.